Company Filing History:
Years Active: 2003
Title: The Innovations of István Gyertyán
Introduction
István Gyertyán is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the brain. His work has implications for the treatment of various neurological conditions.
Latest Patents
Gyertyán holds a patent for a compound titled "8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as AMPA/kainate receptor inhibitors." This patent describes a novel compound that possesses unique competitive AMPA/kainate antagonist properties. The compound is useful in the treatment of diseases where inhibition of the AMPA/kainate receptors may have a favorable effect. The patent also includes a process for preparing the compound and a pharmaceutical composition containing it.
Career Highlights
Gyertyán is associated with Egis Gyógyszergyar Rt., a prominent pharmaceutical company in Hungary. His work at Egis has allowed him to focus on innovative drug development, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Gyertyán has collaborated with notable colleagues, including László Balázs and József Barkóczy. These collaborations have fostered a productive environment for research and development in the pharmaceutical sector.
Conclusion
István Gyertyán's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his role as a key figure in advancing medical science. His work continues to impact the treatment of neurological diseases, showcasing the importance of innovation in healthcare.